Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03969459
Other study ID # PI2017_843_0032
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 28, 2019
Est. completion date February 28, 2023

Study information

Verified date March 2023
Source Centre Hospitalier Universitaire, Amiens
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Epidemiological studies link early exposure to persistent organic pollutants (POPs) with health consequences in the newborn. Experimental studies have shown the impact of POPs on the gut microbiota. This project aims to characterize the POPs content in breast milk in an exposed population and to evaluate the impact on breast milk composition and intestinal microbiota establishment in the newborn. The health consequences will be evaluated by the clinical follow-up of the newborn.


Description:

Picardie is a sub-region with a young population and a high birth rate. The highlighting and the characterization of a maternal exhibition and the newborn will make it possible to know the in utero and postnatal exposure to the pesticides, and if necessary, to implement measures of information and prevention adapted to limit it. The study of pesticide exposure in the periconceptional period, ante and postnatal is crucial because of the vulnerability of this period to the environment and its immediate consequences on the health of the child but also in the long term on the development of chronic pathologies in adulthood. This study will allow us to assess the impact of POPs on the installation of the intestinal microbiota of newborn. 100 mother-child pairs will be included in this project. Samples of 20 mL of breast milk, meconium and stool of newborns will be taken. Gas chromatography or liquid phase analyzes coupled with mass spectrometry will be carried out on breast milk to evaluate the content of persistent organic pollutants and to isolate them. An analysis of the chemical composition of each milk sample will be performed. A bacteriological study for the enumeration of the germs in the mother's milk on the one hand then in the meconium and the saddles of the new-born on the other part will be realized. The DNA of isolated and identified germs will be compared by molecular biology techniques to determine their identity or non-identity within the microbiota of breast milk, meconium and newborn stool. The impact of breast milk contamination by pesticides on the health of newborn will be studied


Recruitment information / eligibility

Status Completed
Enrollment 88
Est. completion date February 28, 2023
Est. primary completion date May 28, 2021
Accepts healthy volunteers No
Gender All
Age group 1 Day to 1 Day
Eligibility Inclusion Criteria: - newborn born before 33 weeks of amenorrhea or at term born at least 37 weeks of amenorrhea - mother aged of 18 to 42 years old at the time of inclusion - mother not deprived of parental rights - signed concerned consent - mother having lived for at least 6 months in the Picardie subregion Exclusion Criteria: - newborn whose term of birth is between 33 and 37 weeks of amenorrhea - mother minor or aged over 42 years - mother deprived of her parental rights

Study Design


Intervention

Biological:
breast milk collection
3 samples of 20 ml of breast milk will be collected between day 0 and day 4; between day 7 and day 15; and between day 21 and day 30 after childbirth.
meconium collection
3 samples of 20 ml of meconium milk will be collected between day 0 and day 4; between day 7 and day 15; and between day 21 and day 30 after childbirth.
newborn feces collection
3 samples of 20 ml of newborn feces will be collected between day 0 and day 4; between day 7 and day 15; and between day 21 and day 30 after childbirth.
Other:
questionary of pesticide exposure of the mother
maternal questionary of pesticide exposure of the mother

Locations

Country Name City State
France CHU Amiens Amiens

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire, Amiens

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary measure of quantity of pesticides in mother's milk the evaluation of the contamination of the mother's milk by pesticides will be done on 20 ml sample of breast milk. between day 0 and day 4 after childbirth
Primary measure of quantity of pesticides in mother's milk the evaluation of the contamination of the mother's milk by pesticides will be done on 20 ml sample of breast milk. between day 7 and day 15 after childbirth
Primary measure of quantity of pesticides in mother's milk the evaluation of the contamination of the mother's milk by pesticides will be done on 20 ml sample of breast milk. between day 21 and day 30 after childbirth
Secondary correlation between measure of quantity of pesticides in mother's milk and microbiota composition in mother's milk correlation between pesticides contamination of mother's milk and microbiota composition in mother's milk between day 0 and day 4 after childbirth
Secondary correlation between measure of quantity of pesticides in mother's milk and microbiota composition in mother's milk correlation between pesticides contamination of mother's milk and microbiota composition in mother's milk between day 7 and day 15 after childbirth
Secondary correlation between measure of quantity of pesticides in mother's milk and microbiota composition in mother's milk correlation between pesticides contamination of mother's milk and microbiota composition in mother's milk between day 21 and day 30 after childbirth
See also
  Status Clinical Trial Phase
Withdrawn NCT03239197 - Project SHARE (motherS Have All the Right microbEs) N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Recruiting NCT06144905 - Norwegian Microbiota Study in Anorexia Nervosa
Completed NCT05864352 - The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health
Recruiting NCT04138979 - Intestinal Microbiota of Breast Cancer Patients Undergoing Chemotherapy
Recruiting NCT04132713 - Study on Skin Microbiome of HFS
Completed NCT05726435 - Effects of Soluble Dietary Fiber on Sport Efficiency and Fatigue Delay in Top Basketball Players N/A
Recruiting NCT02695784 - Probiotics After Discharge Phase 4
Completed NCT03543891 - Intestinal Microbiota and Thyroid Cancer
Completed NCT05242913 - Effects of Resistant Potato Starch on the Gut Microbiota N/A
Recruiting NCT04200521 - The Effect of Bariatric Procedures on Gut Microbiota in Obese Individuals in United Arab Emirates and Lebanon
Recruiting NCT05891977 - Effect of Tomato Paste Consumption on the Microbiota-gut-brain Axis in Healthy Adults N/A
Completed NCT02988349 - Ecological Effect of Arginine Dentifrice on Oral Microbiota N/A
Completed NCT05352724 - Clinical Trial to Evaluate the Efficacy of a Sport Drink After High-intensity Aerobic Exercise N/A
Completed NCT04674839 - The Impact of MS-20 on Gut Microbiota Composition in Adult Individuals N/A
Completed NCT03754504 - Effects of Cranberry Powder Supplements on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT05394948 - Circular Economy and the Design of Healthy and Sustainable Food and Ingredients N/A
Terminated NCT03752372 - Microbiome Alterations in IL10RA-deficient Patients After HSCT
Completed NCT05974124 - Effectiveness of Ophthalmic Antiseptic Preparations N/A
Recruiting NCT02005003 - Cognitive and Metabolic Effects of a Probiotic Supplement N/A